Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Post by aebestaceyon Jun 20, 2018 9:14pm
463 Views
Post# 28202907

He says, " Why aren't WE Talking about this More?"

He says, " Why aren't WE Talking about this More?"

Condition That Can Be Treated with Medical Marijuana

 

Vanessa Milne, Reader's Digest Canada 7 hrs ago

 

About 15 years ago, James O'Hara began experiencing an aching pain and stiffness in his left hip, symptoms that were eventually diagnosed as osteoarthritis. The former banking executive, now 60, managed the condition with Tylenol and Advil for a while, before finally turning to a prescription drug.

 

After a few years, one of the medication's side effects--stomach upset--became so severe that it caused what's known as refractory pain, which travelled up a nerve to O'Hara's left ear.

 

'It was horrific,' he says, and for years he relied on an ever-changing cocktail of prescription medications to combat the side effects from the first one, with varying levels of success.

 

The idea of trying cannabis as an alternative came to O'Hara five years ago, after several of his friends began using it for their own health problems. Despite not having smoked pot regularly since his early 20s, O'Hara experimented with recreational marijuana for pain control and eventually got a formal prescription from a cannabis clinic.

 

'I was shocked at how well it worked,' says O'Hara, who this March became CEO and president of Canadians for Fair Access to Medical Marijuana.

 

'With it, I could function better, and mentally, I was a lot clearer. 'As well as suffering from osteoarthritis, O'Hara experiences focal seiz-ures as a result of an old head trauma, which make him forgetful and disoriented.

 

Since beginning to take medical marijuana, he says these seizures have been reduced by about 85 per cent. On top of that, he believes cannabis helps his chronic asthma.

 

'I was surprised by these unexpected benefits,' he says. 'For me to realize I had gone through my life not knowing that this was available to me made me quite angry. It made me ask,

 

Why aren't we talking about this more?

 


Bullboard Posts